bis(5-amidino-2-benzimidazolyl)methane has been researched along with uk-356,202 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barber, CG; Brown, DG; Butt, R; Collis, MG; Dickinson, RP; Fish, PV; Henry, BT; Horne, VA; Huggins, JP; King, E; McCleverty, D; McIntosh, F; O'Gara, M; Phillips, C; Webster, R | 1 |
1 other study(ies) available for bis(5-amidino-2-benzimidazolyl)methane and uk-356,202
Article | Year |
---|---|
Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidines.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Binding Sites; Chronic Disease; Crystallography, X-Ray; Guanidines; Humans; In Vitro Techniques; Models, Molecular; Protein Binding; Quinolines; Skin; Skin Diseases; Structure-Activity Relationship; Sulfonamides; Swine; Ulcer; Urokinase-Type Plasminogen Activator; Wound Healing | 2007 |